https://www.selleckchem.com/products/gdc-0068.html
hnology. However, more RCTs using narrower age ranges in advanced age women are warranted to corroborate these findings. Although more oocytes were retrieved in patients who underwent r-hFSH monotherapy, this meta-analysis suggests that r-hFSH/r-hLH co-treatment improves clinical pregnancy and implantation rates in women between 35 and 40 years of age undergoing ovarian stimulation for assisted reproduction technology. However, more RCTs using narrower age ranges in advanced age women are warranted to corroborate these findings. Acute